tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VCYT Stock Latest News

Veracyte reports Phase 3 STAMPEDE trial finding published in Cell
The FlyVeracyte reports Phase 3 STAMPEDE trial finding published in Cell
12d ago
VCYT
Veracyte meets targeted enrollment for NIGHTINGALE trial
PremiumThe Fly
Veracyte meets targeted enrollment for NIGHTINGALE trial
13d ago
VCYT
Veracyte management to meet with Craig-Hallum
PremiumThe Fly
Veracyte management to meet with Craig-Hallum
24d ago
VCYT
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns
PremiumRatings
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns
1M ago
VCYT
Veracyte price target lowered to $28 from $29 at Morgan Stanley
PremiumThe Fly
Veracyte price target lowered to $28 from $29 at Morgan Stanley
1M ago
VCYT
Veracyte’s Strong Clinical Evidence and Market Growth Justify Buy Rating
PremiumRatingsVeracyte’s Strong Clinical Evidence and Market Growth Justify Buy Rating
1M ago
VCYT
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones
Premium
Company Announcements
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones
1M ago
VCYT
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
1M ago
VCYT
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating
PremiumRatings
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating
1M ago
VCYT
Veracyte Reports Strong Q2 2025 Revenue Growth
PremiumCompany Announcements
Veracyte Reports Strong Q2 2025 Revenue Growth
1M ago
VCYT
Veracyte sees FY25 revenue $477M-$483M, consensus $491.92M
PremiumThe Fly
Veracyte sees FY25 revenue $477M-$483M, consensus $491.92M
1M ago
VCYT
Veracyte reports Q2 EPS 44c, consensus 30c
PremiumThe Fly
Veracyte reports Q2 EPS 44c, consensus 30c
1M ago
VCYT
BMNR, VCYT, ZG: Cathie Wood Buys $15M More of Ethereum-Linked Bitmine
PremiumMarket NewsBMNR, VCYT, ZG: Cathie Wood Buys $15M More of Ethereum-Linked Bitmine
1M ago
ZG
XYZ
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
Premium
Market News
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
1M ago
ABSI
ARKG
Veracyte to replace Triumph Group in S&P 600 at open on 7/29
Premium
The Fly
Veracyte to replace Triumph Group in S&P 600 at open on 7/29
2M ago
TGI
VCYT
Veracyte Stockholders Approve Key Decisions at Annual Meeting
PremiumCompany Announcements
Veracyte Stockholders Approve Key Decisions at Annual Meeting
3M ago
8K
VCYT
Veracyte to present multiple abstracts at ASCO
PremiumThe Fly
Veracyte to present multiple abstracts at ASCO
3M ago
VCYT
Cautious Outlook on Veracyte: Sell Rating Amid Market Pressures and Execution Risks
PremiumRatings
Cautious Outlook on Veracyte: Sell Rating Amid Market Pressures and Execution Risks
4M ago
VCYT
Veracyte Inc. Reports Strong Q1 2025 Earnings
PremiumCompany Announcements
Veracyte Inc. Reports Strong Q1 2025 Earnings
4M ago
VCYT
Veracyte price target lowered to $42 from $49 at UBS
PremiumThe FlyVeracyte price target lowered to $42 from $49 at UBS
4M ago
VCYT
Veracyte’s Strong Performance and Promising Growth Opportunities Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Performance and Promising Growth Opportunities Justify Buy Rating
4M ago
VCYT
Veracyte Reports Strong Q1 2025 Financial Growth
Premium
Company Announcements
Veracyte Reports Strong Q1 2025 Financial Growth
4M ago
VCYT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >